CASTLE BIOSCIENCES INC 14843C105 US14843C1053 BBG006YWVSR3 05/22/2025 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 N/A 0 NONE WHITEHAWK THERAPEUTICS INC 00032Q104 US00032Q1040 BBG002WN7DT2 06/11/2025 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the Executive Compensation” section of the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 N/A 0 NONE